当前位置:首页 - 行情中心 - 洁特生物(688026) - 财务分析 - 现金流量表

洁特生物

(688026)

  

流通市值:21.90亿  总市值:21.91亿
流通股本:1.40亿   总股本:1.40亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金144,608,224.04658,264,170.34491,068,512.69341,622,290.02
  收到的税费返还3,033,663.395,162,204.565,163,147.43,331,337.12
  收到其他与经营活动有关的现金7,819,785.636,039,231.6524,739,451.7521,094,089.86
  经营活动现金流入小计155,461,673.03699,465,606.55520,971,111.84366,047,717
  购买商品、接受劳务支付的现金84,738,863.28274,107,359.17213,105,003.07150,667,023.53
  支付给职工以及为职工支付的现金33,847,849.31145,098,648.19104,572,683.7570,597,685.1
  支付的各项税费10,107,150.0446,725,633.6736,519,538.9329,490,945.75
  支付其他与经营活动有关的现金5,496,647.3241,774,323.6938,477,286.7231,122,649.91
  经营活动现金流出小计134,190,509.95507,705,964.72392,674,512.47281,878,304.29
  经营活动产生的现金流量净额21,271,163.08191,759,641.83128,296,599.3784,169,412.71
二、投资活动产生的现金流量:
  收回投资收到的现金-587,287,278.37--
  取得投资收益收到的现金-2,951,247.724,068,840.661,958,034.73
  处置固定资产、无形资产和其他长期资产收回的现金净额-308,567.88--
  收到的其他与投资活动有关的现金356,065,600426,300,057.29633,627,942.54430,125,120
  投资活动现金流入小计356,065,6001,016,847,151.26637,696,783.2432,083,154.73
  购建固定资产、无形资产和其他长期资产支付的现金11,222,922.67124,049,648.5975,506,517.8472,943,125.71
  投资支付的现金-567,287,278.37--
  取得子公司及其他营业单位支付的现金7,762,204.12---
  支付其他与投资活动有关的现金346,065,600374,090,656.61629,481,729.14408,797,015.04
  投资活动现金流出小计365,050,726.791,065,427,583.57704,988,246.98481,740,140.75
  投资活动产生的现金流量净额-8,985,126.79-48,580,432.31-67,291,463.78-49,656,986.02
三、筹资活动产生的现金流量:
  吸收投资收到的现金-890,000--
  其中:子公司吸收少数股东投资收到的现金-890,000--
  筹资活动现金流入平衡项目-0--
  筹资活动现金流入小计-890,000--
  分配股利、利润或偿付利息支付的现金-14,597,348.3415,447,128.344,400,190
  其中:子公司支付给少数股东的股利、利润-150,000--
  支付其他与筹资活动有关的现金18,808,175.441,762,079.89738,625.42147,583.2
  筹资活动现金流出小计18,808,175.4416,359,428.2316,185,753.764,547,773.2
  筹资活动产生的现金流量净额-18,808,175.44-15,469,428.23-16,185,753.76-4,547,773.2
四、汇率变动对现金及现金等价物的影响-4,843,367.34-2,154,555.921,858,451.383,410,047.44
五、现金及现金等价物净增加额-11,365,506.49125,555,225.3746,677,833.2133,374,700.93
  加:期初现金及现金等价物余额243,950,502.75118,395,277.38118,395,277.38118,395,277.38
  期末现金及现金等价物余额232,584,996.26243,950,502.75165,073,110.59151,769,978.31
补充资料:
  净利润-49,094,610.55-47,580,111.57
  资产减值准备-26,572,760.61--438,825.26
  固定资产和投资性房地产折旧-52,490,733.76-25,844,334.49
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-52,490,733.76-25,844,334.49
  无形资产摊销-1,560,004.68-626,861.9
  处置固定资产、无形资产和其他长期资产的损失-801,080.79--
  固定资产报废损失-547,737.17-54,293.88
  公允价值变动损失--238,219.18--
  财务费用-30,406,684.34-13,968,316.54
  投资损失--2,181,291.36--1,112,409.37
  递延所得税--3,449,168.33-456,138.92
  其中:递延所得税资产减少--636.41-456,138.92
    递延所得税负债增加--3,448,531.92--
  存货的减少--7,233,009.26-5,521,091.69
  经营性应收项目的减少-57,707,008.29-16,412,602.83
  经营性应付项目的增加--13,399,256.69--24,586,384.98
  债务转为资本-1,125--
  不涉及现金收支的投资和筹资活动金额其他项目-1,802,568.13--
  现金的期末余额-243,950,502.75-151,769,978.31
  减:现金的期初余额-118,395,277.38-118,395,277.38
  现金及现金等价物的净增加额-125,555,225.37-33,374,700.93
公告日期2026-04-302026-04-302025-10-312025-08-30
审计意见(境内)标准无保留意见
TOP↑